Incretin Based Therapy in the Management of Steroid Induced Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|10|6|360-363

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.10, Iss.6, 2014-11, pp. : 360-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance

By  

Current Diabetes Reviews, Vol. 9, Iss. 5, 2013-09 ,pp. : 412-417

Bentham Science Publishers

Access to resources Recommend Favorite

Gene and cell-based therapy for diabetes mellitus: Endocrine gene therapeutics

By Sasaki Takashi   Fujimoto Kei   Sakai Kyoko   Nemoto Masami   Nakai Nozomu   Tajima Naoko  

Endocrine Pathology, Vol. 14, Iss. 2, 2003-06 ,pp. : 141-144

Humana Press, Inc

Access to resources Recommend Favorite

Antiplatelet Therapy in Patients with Diabetes Mellitus

By  

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-07 ,pp. : 494-505

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors

By  

Current Diabetes Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

By Cypryk Katarzyna   Vilsbøll Tina   Nadel Iwona   Smyczynska Joanna   Holst Jens Juul   Lewinski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-01 ,pp. : 58-62

Informa Healthcare

Access to resources Recommend Favorite